期刊文献+

7356例门诊2型糖尿病患者的病情控制分析 被引量:12

Analysis of Clinical Control of Type 2 Diabetes in 7356 Outpatients
下载PDF
导出
摘要 目的 研究门诊2型糖尿病(T2DM)患者的病情控制状况,并分析相关影响因素。方法 按照2002年亚太地区T2DM政策小组推荐的控制目标值,计算内分泌科糖尿病数据库中在库1年以上T2DM患者(A组,n=7356)、建库初期患者(B组,n=1084)以及坚持每月随访患者(C组,n=1367)的血糖、血脂、血压及体质量指数(BMI)的控制达标率,并进行统计学分析比较;同时抽取其中部分患者进行问卷调查,了解影响患者病情控制的相关因素。结果 A组患者共7356例,其糖化血红蛋白(HbAlc)、血压、血脂和BMI控制达标率分别为30%、25.8%、32.6%~81.3%和50.9%;除高密度脂蛋白(HDL)外,其余指标的达标率均高于B组患者相应数值;C组患者共1367例,其主要指标的达标率明显优于A组和B组。问卷调查显示,影响患者病情控制的主要因素包括疾病相关知识的掌握程度低、健康教育的缺乏及有限的专科人才等。结论 绝大多数T2DM患者的病情控制远未达到理想的控制目标,建立和应用科学的疾病管理系统是改善和控制现状的有效方法。 Objective To study the current status of clinical control of outpatients with type 2 diabetes mellitus, and to discuss the factors influencing on disease control. Methods According to the clinical targets recommended by Asian-Pacific Type 2 Diabetes Policy Group, we calculated the success rates of blood glucose, lipid profile, blood pressure and body mass index (BMI) of patients who hospitalized in our department for more than one year( group A, n = 7 356) , and compared these results with the corresponding rates calculated based on the earlier database ( group B, n = 1 084). The success rates of metabolic indexes of patients who insisted on hospitalizing monthly (group C, n = 1 367)were calculated. Besides, the factors influencing disease control were discussed through questionnaire. Results There were 7356 patients in group A, and the success rates of HbAlc, blood pressure, blood lipid profile and BMI were 30% , 25.8% , 32.6%-81.3% and 50.9% , respectively. Except for the parameter of high-density lipoprotein, the other rates were higher than the responding ones of group B. There were 1367 patients in group C, and the success rates of main metabolic indexes were higher than those of group A and B. The result of the question- naire indicated that poor understanding of diatetes, lack of health education, and relative scarcity of diplomate were the main factors that influenced the disease control. Conclusion The disease control of most of the type 2 patients with diabetes are far from satisfaction. The application of scientific disease care system is effective for improving the disease control.
作者 王丽华 刘伟
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第9期987-990,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海交通大学医学院自然科学基金(02XJ21016)资助项目
关键词 2型糖尿病 疾病控制 达标率 影响因素 type 2 diabetes mellitus disease control success rate influence factor
  • 相关文献

参考文献17

  • 1Goldfracht M,Porath A.Nationwide program for improving the care of diabetic patients in Israeli primary care centers[J].Diabetes Care,2000,23(4):495 -499.
  • 2潘长玉.中国糖尿病最新资料搜集研究[J].国外医学(内分泌学分册),2002,22(3):135-138. 被引量:29
  • 3Backlund LB,Algvere PV,Rosenqvist U.New blindness in diabetes reduced by more than one-third in Stockholm County[J].Diabet Med,1997,14(9):732 -740.
  • 4Lipper J,Ritz E,Shwarzbeck A,et al.The rising tide of endstage renal failure from diabetic nephropathy type Ⅱ:an epidemiological study[J].Nephrol Dial Transplant,1995,10(4):462 -467.
  • 5Boulton AJ.Lowering the risk of neuropathy,foot ulcers and amputations[J].Diabet Med,1998,15 (Suppl 4):S57-S59.
  • 6Barnett AH.Treating to goal:challenges of current management[J].Eur J Endocrinol,2004,151 (Suppl 2):T3-T7.
  • 7Eid M,Mafauzy M,Faridah AR.Non-achievement of clinical targets in patients with type 2 diabetes mellitus[J].Med J Malaysia,2004,59(2):177-184.
  • 8Liebl A,Mata M,Eschwege E.Evaluation of risk factors for development of complications in Type Ⅱ diabetes in Europe[J].Diabetologia,2002,45 (7):S23-S28.
  • 9Nilsson PM,Gudbjornsdottir S,Eliasson B,et al.Hypertension in diabetes:trends in clinical control in repeated large-scale national surveys from Sweden[J].J Hum Hypertens,2003,17(1):37 -44.
  • 10Pellegrini F,Belfiglio M,De Berardis G,et al.Role of organizational factors in poor blood pressure control in patients with type 2 diabetes:the QuED Study Group-quality of care and outcomes in type 2 diabetes[J].Arch Intern Med,2003,163 (4):473-480.

二级参考文献12

  • 1贾伟平,于浩泳,项坤三.胰岛素脉冲样分泌的意义及临床应用[J].中华内分泌代谢杂志,2004,20(4). 被引量:6
  • 2潘长玉,田慧,刘国良,李秀钧,傅祖植,陈家伟,暨亚洲糖尿病管理中国协作组.中国城市中心医院糖尿病健康管理调查[J].中华内分泌代谢杂志,2004,20(5):420-424. 被引量:193
  • 3姜素英,左玉华,张和平,徐文,刘芳,贾伟平.社区糖尿病治疗达标现状分析[J].上海医学,2005,28(1):30-32. 被引量:31
  • 4卫生部疾病控制司 中华医学会糖尿病学分会.中国糖尿病防治指南[Z].,2003.4-6.
  • 5DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in IDDM. N Engl J Med, 1993, 329: 977-987.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med, 2000,342:381- 389.
  • 7Nathan DM, l.achin J,Cleary P, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med, 2003,348: 2294-2303.
  • 8UKPAD Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventiional treatment and risk of complications in patients with type 2 diabetes(UKPDS33). Lancet, 1998, 352:837-853.
  • 9Stevens RJ, Coleman RI., Adler AI, et al. Risk factors for myocardial infarction case falality and stroke case fatality in type 2 diabetes. Diabetes Care, 2004, 27: 201-207.
  • 10Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study. Diabetes Care, 1999, 22: 920-924.

共引文献80

同被引文献117

引证文献12

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部